Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 21, 2019 Off

Oragenics Announces Pricing of $12.5 Million Underwritten Public Offering

By BusinessWire

TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective…

March 21, 2019 Off

Customers’ experience leads to a highly successful outcome for Vetter at the 2019 CMO Leadership Awards

By BusinessWire

A win in all six core categories affirms Vetter as a trusted solution provider Vetter performs very well in customer-critical…

March 21, 2019 Off

CORRECTING and REPLACING Investment in Midwest Healthcare Companies Remains Steady at $2.5 Billion in 2018, Validating Record Increase of 43% in 2017

By BusinessWire

Minneapolis, Chicago and Cleveland lead the pack in investment, while the number of Midwest companies receiving funding increases 20% CLEVELAND–(BUSINESS…

Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis
March 21, 2019 Off

Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis

By BusinessWire

OSS, The Netherlands–(BUSINESS WIRE)–Lead Pharma, a pharmaceutical company developing innovative medicines for the treatment of immunological and oncological indications, today…

March 21, 2019 Off

Clinical Trial Management System Market – Global Forecasts from 2019 to 2024: A $1.7+ Billion Opportunity – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Management System Market – Forecasts from 2019 to 2024” report has been added to ResearchAndMarkets.com’s offering.…

Alvogen’s Taiwan company – Lotus – exchange stake with Fuji Pharma
March 21, 2019 Off

Alvogen’s Taiwan company – Lotus – exchange stake with Fuji Pharma

By Dino Mustafić

@alvogenpr subsidiary in Taiwan, Lotus Pharmaceuticals today announced capital and business collaboration agreements with Fuji Pharma in Japan, as Fuji has acquired a 2.0% stake in Lotus for approximately US$20 million (or NT$ 617 million, JPY 2.2 billion). Lotus has also acquired 3.9% stake in Fuji for an equal sum.

Verona Pharma welcomes Non-Executive Director
March 21, 2019 Off

Verona Pharma welcomes Non-Executive Director

By Dino Mustafić

Verona Pharma as Non-Executive Director

New Oasmia board to review business, searching intense dialogue with the stock market and shareholders
March 21, 2019 Off

New Oasmia board to review business, searching intense dialogue with the stock market and shareholders

By Dino Mustafić

The new Oasmia board, led by Jörgen Olsson who was elected as the Chairman, independent Board member and former CEO of Hoist Finance, will review the business and proceedings of Oasmia in several aspects.

March 21, 2019 Off

Investment in Midwest Healthcare Companies Remains Steady at $2.5 Billion in 2018, Validating Record Increase of 43% in 2017

By BusinessWire

Minneapolis, Chicago and Cleveland lead the pack in investment, while the number of Midwest companies receiving funding increases 20% CLEVELAND–(BUSINESS…

Gelesis Announces Three Presentations at Annual Endocrine Society Meeting
March 21, 2019 Off

Gelesis Announces Three Presentations at Annual Endocrine Society Meeting

By BusinessWire

BOSTON–(BUSINESS WIRE)–Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI)…

Posts pagination

Previous 1 … 3,341 3,342 3,343 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine